• menu
    Market Place Market Place
    Sourcing support Sourcing Support
    API / FDF
    Excipients
    Services
    Developments
    News
    Market Intel
    #Phispers
    #SpeakPharma
    #LearnMore

    NEWS

    DRUGS & DEVELOPMENTS

    MARKET INTEL by PharmaCompass

    SPI Pharma has been solving formulation challenges using superior functional materials.

    Juvena Therapeutics Starts First-in-Human Trial of JUV-161

    GLOBENEWSWIRE

    Juvena Therapeutics Receives FDA Orphan Drug Designation for JUV-161

    BUSINESSWIRE

    Juvena Therapeutics Bolsters Leadership Team With Key Industry Veterans

    BUSINESSWIRE

    Juvena Therapeutics Secures $41 M to Accelerate the Discovery and Development

    BUSINESSWIRE

    Copyright © 2025 LePro PharmaCompass OPC Private Limited, All rights reserved.